Chandrashekhar Honrao

发表

A new antibiotic selectively kills Gram-negative pathogens

K. Nelson, M. Savitski, A. Typas, 2019, Nature.

Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite

M. Malamas, A. Makriyannis, J. Wood, 2020, Frontiers in Pharmacology.

( R)- N-(1-Methyl-2-hydroxyethyl)-13-( S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes.

K. Mackie, L. Marnett, A. Hohmann, 2018, Journal of medicinal chemistry.

Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic Analogues.

S. Nikas, A. Makriyannis, J. Bergman, 2016, Journal of medicinal chemistry.

Oximes short-acting CB1 receptor agonists.

M. Malamas, J. Wood, Han Zhou, 2018, Bioorganic & medicinal chemistry.

Evybactin is a DNA gyrase inhibitor that selectively kills Mycobacterium tuberculosis

J. Berger, D. Baldisseri, K. Lewis, 2022, Nature Chemical Biology.

Gadolinium-Based Paramagnetic Relaxation Enhancement Agent Enhances Sensitivity for NUS Multidimensional NMR-Based Metabolomics

R. Powers, Elizabeth M. O'Day, Chandrashekhar Honrao, 2021, Molecules.

Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients

C. Dong, L. Rodrigues, Elizabeth M. O'Day, 2022, Metabolites.

Cannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis

I. Galynker, Y. Hurd, C. Gibson, 2023, Journal of psychopharmacology.